Assessment of current clinical practices for major depression in Japan using a web-based questionnaire

References

• Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119–138. doi:10.1146/annurev-publhealth-031912-11440923514317
   PubMed Web of Science ®Google Scholar
• Hasler G. Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry. 2010;9(3):155–161. doi:10.1002/wps.2010.9.issue-320975857
   PubMed Web of Science ®Google Scholar
• Okumura Y, Higuchi T. Cost of depression among adults in Japan. Prim Care Companion CNS Disord. 2011;13(3):PCC.10m01082. doi:10.4088/PCC.10m01072
   Google Scholar
• Sato S, Yeh TL. Challenges in treating patients with major depressive disorder: the impact of biological and social factors. CNS Drugs. 2013;27(Suppl 1):S5–S10. doi:10.1007/s40263-012-0028-823712795
   PubMed Web of Science ®Google Scholar
• Furukawa TA, Kitamura T, Takahashi K. Treatment received by depressed patients in Japan and its determinants: naturalistic observation from a multi-center collaborative follow-up study. J Affect Disord. 2000;60(3):173–179. doi:10.1016/S0165-0327(99)00175-511074105
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Kawakami N, Kessler RC, World Mental Health Japan Survey C. Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey. Epidemiol Psychiatr Sci. 2016;25(3):217–229. doi:10.1017/S204579601500056626148821
   PubMed Web of Science ®Google Scholar
• Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547. doi:10.1371/journal.pmed.100154724223526
   PubMed Web of Science ®Google Scholar
• World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization; 2017 Available from: http://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf. Accessed 1015, 2018.
   Google Scholar
• Ho SC, Chong HY, Chaiyakunapruk N, Tangiisuran B, Jacob SA. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affect Disord. 2016;193:1–10. doi:10.1016/j.jad.2015.12.02926748881
   PubMed Web of Science ®Google Scholar
• Alekhya P, Sriharsha M, Venkata Ramudu R, et al. Adherence to antidepressant therapy: sociodemographic factor wise distribution. Int J Pharm Clin Res. 2015;7(3):180–184.
   Google Scholar
• Martín Vázquez M, García-Toro M, Campoamor F, Pareja A.Uso de los tratamientos antidepresivos. La percepción del paciente [Use of antidepressant treatments. Patient perception]. Actas Esp Psiquiatr. 2015;37(5):276–281. Spanish.
   Google Scholar
• Martín Vázquez M, García-Toro M, Campoamor F, et al. Use and results of antidepressant treatment: patients’ perception. Curr Drug Ther. 2011;6(4):271–277. doi:10.2174/157488511798109619
   Google Scholar
• Sansone RA, Sansone LA. Antidepressant adherence: are patients taking their medications? Innov Clin Neurosci. 2012;9(5–6):41–46.22808448
   PubMedGoogle Scholar
• Tamburrino MB, Nagel RW, Chahal MK, Lynch DJ. Antidepressant medication adherence: a study of primary care patients. Prim Care Companion J Clin Psychiatry. 2009;11(5):205–211. doi:10.4088/PCC.08m0069419956457
   PubMedGoogle Scholar
• Pompili M, Venturini P, Palermo M, et al. Mood disorders medications: predictors of nonadherence - review of the current literature. Expert Rev Neurother. 2013;13(7):809–825. doi:10.1586/14737175.2013.81197623898852
   PubMed Web of Science ®Google Scholar
• Lam RW, Kennedy SH, McLntyre RS, Khullar A. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry. 2014;59(12):649–654. doi:10.1177/07067437140590120625702365
   PubMed Web of Science ®Google Scholar
• MacQueen GM, Memedovich KA. Cognitive dysfunction in major depression and bipolar disorder: assessment and treatment options. Psychiatry Clin Neurosci. 2017;71(1):18–27. doi:10.1111/pcn.2017.71.issue-127685435
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Ionescu DF. Updates and trends in the treatment of major depressive disorder. J Clin Psychiatry. 2014;75(12):1419–1421. doi:10.4088/JCP.14ac0961025551237
   PubMed Web of Science ®Google Scholar
• Hammer-Helmich L, Haro JM, Jonsson B, et al. Functional impairment in patients with major depressive disorder: the 2-year PERFORM study. Neuropsychiatr Dis Treat. 2018;14:239–249. doi:10.2147/NDT.S14609829386897
   PubMed Web of Science ®Google Scholar
• El Hammi E, Samp J, Remuzat C, et al. Difference of perceptions and evaluation of cognitive dysfunction in major depressive disorder patients across psychiatrists internationally. Ther Adv Psychopharmacol. 2014;4(1):22–29. doi:10.1177/204512531350794624490027
   PubMedGoogle Scholar
• Knight MJ, Air T, Baune BT. The role of cognitive impairment in psychosocial functioning in remitted depression. J Affect Disord. 2018;235:129–134. doi:10.1016/j.jad.2018.04.05129655074
   PubMed Web of Science ®Google Scholar
• Knight MJ, Baune BT. Executive function and spatial cognition mediate psychosocial dysfunction in major depressive disorder. Front Psychiatry. 2018;9:539. doi:10.3389/fpsyt.2018.0053930420817
   PubMed Web of Science ®Google Scholar
• Knight MJ, Fourrier C, Lyrtzis E, et al. Cognitive deficits in the THINC-integrated tool (THINC-it) are associated with psychosocial dysfunction in patients with major depressive disorder. J Clin Psychiatry. 2018;80(1):18m12472. doi:10.4088/JCP.18m12472
   Web of Science ®Google Scholar
• Iga J-I, Uchiyama M, Ohmori T, et al. The Japanese Society of Mood Disorders Treatment Guideline. Tokyo: The Japanese Society of Mood Disorders Treatment; 2016 Available from: http://www.secretariat.ne.jp/jsmd/mood_disorder/img/160731.pdf. Accessed 1015, 2018.
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington (DC): American Psychiatric Publishing; 2013.
   Google Scholar
• Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016;61(9):540–560. doi:10.1177/070674371665941727486148
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Depression in adults: recognition and management. 2018 Available from: https://www.nice.org.uk/guidance/cg90. Accessed 1015, 2018.
   Google Scholar
• Sumiyoshi T, Watanabe K, Noto S, Sakamoto S, Moriguchi Y, Okamoto S. Prospective epidemiological research on functioning outcomes related to major depressive disorder in Japan (PERFORM-J): protocol for a prospective cohort study. JMIR Res Protoc. 2018;7(6):e161. doi:10.2196/resprot.968229941418
   PubMed Web of Science ®Google Scholar
• Ragguett RM, Cha DS, Kakar R, Rosenblat JD, Lee Y, McIntyre RS. Assessing and measuring cognitive function in major depressive disorder. Evid Based Ment Health. 2016;19(4):106–109. doi:10.1136/eb-2016-10245627935809
   PubMed Web of Science ®Google Scholar
• Lam RW, Michalak EE, Bond DJ, Tam EM, Axler A, Yatham LN. Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning? Depress Res Treat. 2012;2012:630206.22611491
   PubMedGoogle Scholar
• Chokka P, Bougie J, Rampakakis E, Proulx J. Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD). CNS Spectr. 2018;24:1–10.
   Web of Science ®Google Scholar
• Liu X, Jiang K. Why is diagnosing MDD challenging? Shanghai Arch Psychiatry. 2016;28(6):343–345.28638210
   PubMedGoogle Scholar
• Gilmour G, Porcelli S, Bertaina-Anglade V, et al. Relating constructs of attention and working memory to social withdrawal in Alzheimer’s disease and schizophrenia: issues regarding paradigm selection. Neurosci Biobehav Rev. 2019;97:47–69.30399355
   PubMed Web of Science ®Google Scholar
• Baune BT, Sluth LB, Olsen CK. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: a short-term, randomized, double-blind, exploratory study. J Affect Disord. 2018;229:421–428. doi:10.1016/j.jad.2017.12.05629331703
   PubMed Web of Science ®Google Scholar
• Jaeger J. Digit symbol substitution test: the case for sensitivity over specificity in neuropsychological testing. J Clin Psychopharmacol. 2018;38(5):513–519. doi:10.1097/JCP.000000000000094130124583
   PubMed Web of Science ®Google Scholar
• Progress in Mind - Psichiatry & Neurology Resource Center. THINC-it® physician guide. 2017 Available from: https://progress.im/en/content/thinc-it%C2%AE-physician-guide. Accessed 726, 2019.
   Google Scholar
• Harrison JE, Barry H, Baune BT, et al. Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: a psychometric exploration in healthy volunteers. Int J Methods Psychiatr Res. 2018;27(3):e1736. doi:10.1002/mpr.173630088298
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Best MW, Bowie CR, et al. The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder. J Clin Psychiatry. 2017;78(7):873–881. doi:10.4088/JCP.16m1132928858441
   PubMed Web of Science ®Google Scholar
• Ministry of Health Labour and Welfare Japan. Supplementary material: HDS-R evaluation sheet and supplementary explanation on the index of stratification [Japanese]. 2009 Available from: https://www.mhlw.go.jp/topics/2009/05/dl/tp0501-sankou7-2.pdf. Accessed 117, 2019.
   Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.1202204
   PubMed Web of Science ®Google Scholar
• Tabuse H, Kalali A, Azuma H, et al. The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Res. 2007;153(1):61–67. doi:10.1016/j.psychres.2006.07.00417445908
   PubMed Web of Science ®Google Scholar
• Naganuma H. Mood disorders: Manic episode [Japanese]. Rinsho Seishin Igaku. 1999;28(Suppl):128–134.
   Google Scholar
• Japanese Society of Neurology. Guidelines for Neurological Examination. Tokyo: Japanese Society of Neurology; 2002 Available from: https://www.neurology-jp.org/news/news_20080715_01.html. Accessed 1115, 2018.
   Google Scholar